This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hashibe, M. Articles by Boffetta, P. Search for Related Content PubMed PubMed Citation Articles by Hashibe, M. Articles by Boffetta, P.

Meta- and Pooled Analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 Genotypes and Risk of Head and Neck Cancer

¹ International Agency for Research on Cancer, Lyon, France; ² Keele University, Staffordshire, United Kingdom; ³ Cancer Research Institute, Mumbai, India; ⁴ University of Greifswald, Greifswald, Germany; ⁵ H. Lee Moffitt Cancer Center, University of South Florida, Tampa, Florida; ⁶ University of Maastricht, Maastricht, the Netherlands; ⁷ INSERM-Evry University, Evry, France; ⁸ McGill University, Montreal, Quebec, Canada; ⁹ Miyazaki Medical College, Miyazaki, Japan; ¹⁰ Université de Bordeaux II, Bordeaux, France; ¹¹ University of Pittsburgh, Pittsburgh, Pennsylvania; and ¹² Ospedale Maggiore IRCCS, Milan, Italy

Sequence variation in the GSTM1, GSTT1, GSTP1, and CYP1A1 genes may potentially alter susceptibility to head and neck cancers, although evidence from previous studies has not been consistent. To explore these associations, we conducted a meta-analysis of 31 published case–control studies (4635 cases and 5770 controls) and a pooled analysis of original data from nine published and two unpublished case–control studies (2334 cases and 2766 controls). In the meta-analysis, the summary odds ratios (ORs) for head and neck cancer were 1.23 [95% confidence interval (95% CI), 1.06–1.42] for the GSTM1 null genotype, 1.17 (95% CI, 0.98–1.40) for the GSTT1 null genotype, 1.10 (95% CI, 0.92–1.31) for carrying the GSTP1 Val105 allele, and 1.35 (95% CI, 0.95–1.82) for carrying the CYP1A1 Val462 allele. The pooled analysis ORs were 1.32 (95% CI, 1.07–1.62) for the GSTM1 null genotype, 1.25 (95% CI, 1.00–1.57) for the GSTT1 null genotype, 1.15 (95% CI, 0.86–1.53) for carrying the GSTP1 Val105 allele, and 0.98 (95% CI, 0.75–1.29) for carrying the CYP1A1 Val462 allele. Increasing risk of head and neck cancer was observed with inheritance of increasing numbers of modest risk genotypes at the three GST loci (P for trend = 0.04), with the combination of carrying the GSTM1 null, GSTT1 null, and GSTP1 Val105 alleles conferring an OR of 2.06 (95% CI, 1.11–3.81). In conclusion, both the meta- and pooled analysis support modest associations of GSTM1 and GSTT1 genotypes with head and neck cancer risk, and our pooled analysis supports the notion of greater risk when genotypes at multiple GST loci are considered in a multigenic model.

This article has been cited by other articles:

				J. P. A. Ioannidis Effect of Formal Statistical Significance on the Credibility of Observational Associations Am. J. Epidemiol., July 8, 2008; (2008) kwn156v1. [Abstract] [Full Text] [PDF]

				X. Guo, S. J. O'Brien, Y. Zeng, G. W. Nelson, and C. A. Winkler GSTM1 and GSTT1 Gene Deletions and the Risk for Nasopharyngeal Carcinoma in Han Chinese Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1760 - 1763. [Abstract] [Full Text] [PDF]

				D. Anantharaman, P. M. Chaubal, S. Kannan, R. A. Bhisey, and M. B. Mahimkar Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator Carcinogenesis, July 1, 2007; 28(7): 1455 - 1462. [Abstract] [Full Text] [PDF]

				E. Kellen, M. Hemelt, K. Broberg, K. Golka, V. N. Kristensen, R. J. Hung, G. Matullo, R. D. Mittal, S. Porru, A. Povey, et al. Pooled Analysis and Meta-analysis of the Glutathione S-Transferase P1 Ile 105Val Polymorphism and Bladder Cancer: A HuGE-GSEC Review Am. J. Epidemiol., June 1, 2007; 165(11): 1221 - 1230. [Abstract] [Full Text] [PDF]

				E. S. Peters, M. D. McClean, C. J. Marsit, B. Luckett, and K. T. Kelsey Glutathione S-Transferase Polymorphisms and the Synergy of Alcohol and Tobacco in Oral, Pharyngeal, and Laryngeal Carcinoma. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2196 - 2202. [Abstract] [Full Text] [PDF]

				T. Ho, C. Zhao, R. Zheng, Z. Liu, Q. Wei, and E. M. Sturgis Glutathione s-transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis. Arch Otolaryngol Head Neck Surg, July 1, 2006; 132(7): 756 - 761. [Abstract] [Full Text] [PDF]

				S. Boccia, G. La Torre, F. Gianfagna, A. Mannocci, and G. Ricciardi Glutathione S-transferase T1 status and gastric cancer risk: a meta-analysis of the literature Mutagenesis, March 1, 2006; 21(2): 115 - 123. [Abstract] [Full Text] [PDF]

				J. Cloos, W. P.H. de Boer, M. H.J. Snel, P. van den IJssel, B. Ylstra, C. R. Leemans, R. H. Brakenhoff, and B. J.M. Braakhuis Microarray Analysis of Bleomycin-Exposed Lymphoblastoid Cells for Identifying Cancer Susceptibility Genes Mol. Cancer Res., February 1, 2006; 4(2): 71 - 77. [Abstract] [Full Text] [PDF]

				R. Lai, L. Crevier, and L. Thabane Genetic Polymorphisms of Glutathione S-Transferases and the Risk of Adult Brain Tumors: A Meta-analysis Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1784 - 1790. [Abstract] [Full Text] [PDF]

				C. Ntais, A. Polycarpou, and J. P.A. Ioannidis Association of GSTM1, GSTT1, and GSTP1 Gene Polymorphisms with the Risk of Prostate Cancer: A Meta-analysis Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 176 - 181. [Abstract] [Full Text] [PDF]